Navigation Links
Iron induces death in tumor cells
Date:3/11/2009

Rapid growth of cancer cells and their frequent divisions have their price: Cancer cells need considerably more energy than healthy cells. Their metabolism runs at full speed and requires large amounts of micronutrients, particularly iron. However, high levels of iron in the cell lead to the production of extremely harmful free radicals. To protect itself from these, the cell inactivates free iron by binding it to what are called iron storage proteins.

Collaborating with physicians of the Dermatology Department of Mannheim University Hospitals, Dr. Karsten Glow and Professor Dr. Peter Krammer, head of the Division of Immunogenetics at DKFZ, investigated Szary's disease (also called Szary syndrome), an extremely aggressive type of cutaneous T cell lymphoma. The majority of currently available treatments are not really effective against this fatal type of cancer.

Using a molecular-biological trick, Glow and colleagues succeeded in blocking the production of one of the iron storage proteins in lymphoma cells. This leads to a rise in the level of free, non-bound iron in these cells. The iron boosts the production of free oxygen radicals which cause oxidative stress and, thus, cause damage to the cancer cells and induce their death. Healthy cells with their low iron level, however, survive the treatment unharmed.

The DKFZ researchers have already found evidence that this iron effect also works in other lymphomas. They are now investigating whether selective release of iron may be a suitable approach for developing a novel cancer treatment.


'/>"/>

Contact: Dr. Sibylle Kohlstdt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1

Related medicine news :

1. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
2. High zinc status in lung cells slows growth and induces DNA damage-induced gene expression
3. Common anesthetic induces Alzheimers-associated changes in mouse brains
4. Penn study finds pro-death proteins required to regulate healthy immune function
5. Study, meta-analysis examine factors associated with death from heatstroke
6. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
7. Diabetes appears to increase risk of death for patients with acute coronary syndromes
8. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
9. Longer ambulance journeys boost death risk for seriously ill patients
10. Stopping Statins After Stroke Doubles Death Risk
11. Oral Health a Matter of Life and Death for Seniors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed ... of its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada ... Inc., plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that ...
(Date:7/21/2017)... Ridge, NJ (PRWEB) , ... July 21, 2017 ... ... (VNA) has received a $5,000 grant from the C. R. Bard ... Adult Day Center at Somerset Hills , a service available through the nonprofit ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the newest ... 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic ... skin cancer , and more. She graduated from the University of Florida College of ...
(Date:7/21/2017)... ... 21, 2017 , ... The most common surgical techniques used ... life five years after injury, according to research presented today at the ... The study followed patients for five years following surgery. , “Orthopaedic surgeons have ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
(Date:7/10/2017)... 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. The ... global decision makers and innovative biotech startup companies. The ... during two impactful days. BioPharm America is now part ... networking opportunities with 4,500+ life science industry influencers participating ...
Breaking Medicine Technology: